Event-Driven Stocks

PROCEPT BioRobotics Corp

PRCTNasdaq

Healthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 3 good● 4 warningdetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$308.1M$224.5M$136.2M$75.0M$34.5M$7.7M
Operating income−$103.9M−$96.6M−$109.2M−$80.7M−$54.2M−$47.8M
Net income−$95.6M−$91.4M−$105.9M−$87.2M−$59.9M−$53.0M
Total assets$508.1M$534.0M$404.7M$309.3M$337.0M$126.0M
Total liabilities$142.2M$131.8M$124.0M$112.3M$69.9M$65.0M
Equity$365.9M$402.2M$280.8M$197.1M$267.1M−$182.9M
EPS (diluted)$-1.72$-1.75$-2.24$-1.96$-3.63$-14.47
Shares out.54.8M51.0M44.9M44.0M43.7M4.7M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−33.7%
Net margin
−31.0%
Return on equity
−26.1%
Return on assets
−18.8%
Return on capital (ROCE)
−23.5%
Liabilities / assets
28.0%
Debt / equity
0.39×
Book value / share
$6.67
Revenue growth (YoY)
37.2%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
2.18grey zone
Accruals / assets
−9.2%clean
Beneish M-Score
-2.84normal
Piotroski F-Score
3/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
55
/ 100
Profitability 0Growth 100Catalyst 33Earnings quality 67Financial strength 75

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 4 warning● 3 good
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Negative operating cash flow
  • Altman Z″ in the grey zone
  • Revenue is growing year-over-year
  • Conservative leverage (liabilities < 50% of assets)
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 20266.7M4.0+11.9%
Apr 30, 20266.0M4.2+3.0%
Apr 15, 20265.8M4.5-0.6%
Mar 31, 20265.9M4.7-9.8%
Mar 13, 20266.5M2.7+1.8%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)